Malignant Pleural Mesothelioma with Pleural Plaques: A Case Report
Main Article Content
Abstract
Diffuse malignant mesothelioma (DMM) is an aggressive tumor of the mesothelium associated with a poor prognosis. Asbestos exposure is the major cause of the disease. Furthermore, pleural plaques are also caused by asbestos exposure. The authors present a case with malignant pleural mesothelioma and pleural plaques.
Article Details
How to Cite
1.
Dumavibhat N, Ruangchira-urai R, Muangman N, Thongcharoen P, Bunman S, Jaroonpipatkul A. Malignant Pleural Mesothelioma with Pleural Plaques: A Case Report. BKK Med J [Internet]. 2018 Feb. 20 [cited 2024 Dec. 23];14(1):43. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/222249
Section
Case Report
This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
1. Lynette MS, Marina V. Epidemiology. In: Allen TC, editor. Diffuse Malignant Mesothelioma. Springer New York;2015:3-32.
2. Robinson BM. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg. 2012;1(4):491–6.
3. Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos.Ind Health. 2007;45:379-87.
4. Driscoll T, Nelson DI, Steenland K, et al. The global burden of disease due to occupational carcinogens. Am J Ind Med. 2005;48(6):419-31.
5. Spirtas R, Heineman EF, Bernstein L, et al. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 1994;51(12):804–11.
6. Craighead JE. Epidemiology of mesothelioma and historical background. In: Tannapfel A, editor.Malignant mesothelioma. Heidelberg: Springer;2011:13-25.
7. World Health Organization. Chrysotile asbestos [Internet]. Geneva: WHO;2014.[cited 2018 Jan 5]. Available from:www. who.int/ipcs/assessment/public.../chrysotile_asbestos_summary. pdf
8. Maxim LD, Niebo R, Utell MJ. Are pleural plaques an appropriate endpoint for risk analyses? InhalToxicol. 2015;27(7):321-34.
9. Hillerdal G, Henderson D. (1997). Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health. 23:93–103.
10. Subhannachart P, Dumavibhat N, Siriruttanapruk S. Asbestosrelated diseases in Thailand and review literature. J Med Assoc Thai. 2012;95(Suppl 8):S71-6
11. Chuaychoo B, Luangdansakun N, Chierakul N, et al. Pathological confirmed diagnosis of asbestosis: the first case report in Thailand. J. Med. Assoc. Thai. 2015;98(3):314-19.
2. Robinson BM. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg. 2012;1(4):491–6.
3. Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos.Ind Health. 2007;45:379-87.
4. Driscoll T, Nelson DI, Steenland K, et al. The global burden of disease due to occupational carcinogens. Am J Ind Med. 2005;48(6):419-31.
5. Spirtas R, Heineman EF, Bernstein L, et al. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 1994;51(12):804–11.
6. Craighead JE. Epidemiology of mesothelioma and historical background. In: Tannapfel A, editor.Malignant mesothelioma. Heidelberg: Springer;2011:13-25.
7. World Health Organization. Chrysotile asbestos [Internet]. Geneva: WHO;2014.[cited 2018 Jan 5]. Available from:www. who.int/ipcs/assessment/public.../chrysotile_asbestos_summary. pdf
8. Maxim LD, Niebo R, Utell MJ. Are pleural plaques an appropriate endpoint for risk analyses? InhalToxicol. 2015;27(7):321-34.
9. Hillerdal G, Henderson D. (1997). Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health. 23:93–103.
10. Subhannachart P, Dumavibhat N, Siriruttanapruk S. Asbestosrelated diseases in Thailand and review literature. J Med Assoc Thai. 2012;95(Suppl 8):S71-6
11. Chuaychoo B, Luangdansakun N, Chierakul N, et al. Pathological confirmed diagnosis of asbestosis: the first case report in Thailand. J. Med. Assoc. Thai. 2015;98(3):314-19.